Eupraxia Pharmaceuticals (EPRX) Earnings Date & Reports

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

EPRX is expected to report earnings to -22 cents per share on August 07

Eupraxia Pharmaceuticals EPRX Stock Earnings Reports

Q2'26

Est.

$-0.22

Q1'26

Missed

by $0.04

Q4'25

Missed

by $0.17

Q3'25

Missed

by $0.01

Q2'25

Missed

by $0.06

The last earnings report on May 12 showed earnings per share of -22 cents, missing the estimate of -18 cents. With 141.12K shares outstanding, the current market capitalization sits at 395.04M.

View a ticker or compare two or three

Compare

EPRX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for EPRX